In particular, we demonstrated the role of IL8, the most potent neutrophil-recruiting chemokine in humans, in the development of NASH, which has not been previously examined in experimental model organisms owing to interspecies differences in IL8 expression. The gene discussed is CXCL8; the disease is metabolic dysfunction-associated steatohepatitis.